EFFICACY OF DANAZOL IN A PATIENT WITH CONGENITAL PROTEIN S DEFICIENCY: PARADOXICAL EVIDENCE FOR DECREASED PLATELET ACTIVATION WITH INCREASED THROMBIN GENERATION
This case report details the paradoxical observation of decreased platelet activation alongside increased thrombin generation in a patient with congenital protein S deficiency treated with danazol.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
My notes (saved in your browser only)
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (40)
- A Comparison of Plasma Protein Changes Induced by Danazol, Pregnancy, and Estrogens* via openalex
- Danazol Therapy in Hypoplasminogenemia via openalex
- Effect of danazol on clotting factor levels, bleeding incidence, factor infusion requirements, and immune parameters in hemophilia via openalex
- Failure of the Synthetic Androgen, Danazol, to Increase Protein S Levels and Prevent Thrombosis in a Patient with Severe Protein S Deficiency via openalex
- Hereditary antithrombin III deficiency: Case report and review of recent therapeutic advances via openalex
- Protein C Deficiency – Response to Danazol and DDAVP via openalex
- Protein S Deficiency Associated to Anti-Protein S Antibodies in a Patient with Mixed Connective-Tissue Disease and Its Reversal by Danazol via openalex
- Significant elevation of protein C and protein S levels in thrombotic disorders by low dose danazol via openalex
- Some clotting factors in plasma during danazol therapy: free and total protein S, but not C4b-binding protein, are elevated by danazol therapy. via openalex
- Treatment of Familial Antithrombin-III Deficiency with Danazol via openalex
- doi:10.1182/blood.v84.4.1031.1031 via openalex
- doi:10.1136/bmj.298.6668.233 via openalex
- doi:10.1055/s-0038-1649578 via openalex
- doi:10.1038/359848a0 via openalex
- doi:10.1055/s-0038-1646998 via openalex
- W6659365921 via openalex
- W6663757243 via openalex
- W6714498700 via openalex
- doi:10.1016/0091-6749(80)90181-5 via openalex
- doi:10.1159/000204398 via openalex
- doi:10.1055/s-0038-1650308 via openalex
- doi:10.1016/0049-3848(94)00138-4 via openalex
- doi:10.1016/0091-6749(81)90181-0 via openalex
- doi:10.1182/blood.v71.2.370.370 via openalex
- doi:10.1182/blood.v59.5.1086.1086 via openalex
- doi:10.1055/s-0038-1651054 via openalex
- doi:10.1111/j.1365-2141.1986.tb07559.x via openalex
- doi:10.7326/0003-4819-108-6-910_1 via openalex
- doi:10.1016/0049-3848(84)90165-8 via openalex
- doi:10.1111/j.1365-2141.1984.tb02927.x via openalex
- doi:10.1055/s-0038-1661049 via openalex
- doi:10.1055/s-0038-1650046 via openalex
- doi:10.1182/blood.v73.5.1109.1109 via openalex
- doi:10.7326/0003-4819-106-6-910_2 via openalex
- doi:10.1055/s-0038-1649840 via openalex
- doi:10.1055/s-0038-1651603 via openalex
- doi:10.1182/blood.v82.1.107.bloodjournal821107 via openalex
- doi:10.1055/s-0038-1642681 via openalex
- doi:10.1136/bmj.295.6599.641 via openalex
- doi:10.1016/s0140-6736(84)92816-2 via openalex
Cited by (4)
- Development and validation of TLC-densitometric method for the quantification of a steroidal drug, danazol in its pharmaceutical formulations 2012
- Management of Menorrhagia Associated with Chemotherapy‐Induced Thrombocytopenia in Women with Hematologic Malignancy 2011
- Efficacy of vaginal danazol treatment in women with menorrhagia during fertile age 2008
- Efficacy of vaginal danazol treatment in women with recurrent deeply infiltrating endometriosis 2007
Source provenance
- openalex
- last seen: 2026-05-11T05:55:38.273849+00:00